ACTA1 and breast cancer: In vitro 3D culture experiments demonstrated that when cultured in high-density and aligned ECM, CAFs can increase the expression of α-SMA and fibronectin while reduce the secretion of IL-2, thereby inhibiting T cell activation and accelerating breast cancer progression [88].